Document Collaboration, Controlled

Drug development is an inherently document-intensive process and requires meticulous attention. In the highly regulated life sciences industry, effective collaboration on critical documents goes far beyond convenience—it’s about maintaining control, ensuring traceability, and guaranteeing accuracy at every stage. This is why leading organizations such as Lexicon, GenMab, Galderma, Novartis, uniQure, Ferring, and Imvax rely on Ideagen Document Review (formerly PleaseReview) to streamline their complex document review workflows.

Ideagen Document Review empowers teams to accelerate review cycles by minimizing manual tasks while also maintaining comprehensive audit trails that support compliance and regulatory readiness. It eliminates the chaos of version sprawl and reduces dependence on email-based reviews to foster seamless collaboration across internal departments and external stakeholders. While tools like Microsoft Word and SharePoint are effective for drafting and early-stage collaboration, they often fall short during high-stakes, late-stage reviews. Ideagen Document Review is purpose-built to handle these challenges, complementing Microsoft 365 rather than replacing it.

This brochure offers a behind-the-scenes look at how Ideagen Document Review has delivered measurable results. Learn how to elevate your document review process and reduce the risks associated with manual, fragmented workflows.